Early Life and Education
Wayne Rothbaum was born on February 17, 1968, and is currently 58 years old. He earned a Bachelor of Arts/Science from the State University of New York at Binghamton and a Master of Arts in international economics from The George Washington University.
Rise to Success
Rothbaum began his career at The Carson Group, where he managed the life sciences practice and a boutique investment bank. In 2001, he founded Quogue Capital, a single-family office private equity fund that focuses on supporting small to mid-cap life sciences companies.
Rothbaum's investment strategy led him to become a prominent figure in biotech investing. His backing of Acerta Pharma, a cancer drug developer, is considered one of the greatest biotech investments of all time. He co-founded Acerta Pharma in 2012, serving as its executive chairman. In 2016, AstraZeneca acquired 55% of Acerta Pharma, and the remaining portion was acquired between 2022 and 2024. Rothbaum is also the executive chair of Kartos Therapeutics and Telios Pharma, both focused on cancer drug development. Rothbaum also led a restructuring of Iovance Biotherapeutics, where he is a board member and the largest shareholder, with a 9% stake.
Key Business Strategies
Rothbaum deploys his own funds for investments, emphasizing his personal conviction and expertise in the biotech field. His strategies include identifying and investing in innovative companies developing cancer therapies. He focuses on long-term value creation by supporting the growth of these companies and contributing to the advancement of medical treatments. Rothbaum's hands-on approach involves taking leadership roles within the companies he invests in, as seen with Iovance Biotherapeutics.
Philanthropy
Rothbaum has donated $300 million to SUNY Binghamton for a sports complex and scholarships, as well as to Ohio State University to build housing for cancer patients.
